Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Claire Verschraegen, M.D.
New Mexico Cancer Research Alliance
Principal Investigator - David Alberts, MD
University of Arizona
Principal Investigator - Jeffrey Goldberg, MD
Louisville Oncology Clinical Research Program
Principal Investigator - Krishnansu Tewari, MD
UCI Chao Family Comprehensive Cancer Center
Principal Investigator - Larry Puls, MD
Gynecologic Oncology Research & Development, LLC
Principal Investigator - Michael Gordon, MD
Premiere Oncology of Arizona
Principal Investigator - Nashat Gabrail, MD
Gabrail Cancer Center
Principal Investigator - Peter D Eisenberg, MD
California Cancer Center
Principal Investigator - William Robinson, MD
Harrington Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Premiere Oncology of Arizona
Scottsdale, Arizona, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- California Cancer Center
Greenbrae, California, United States
- Uci Chao Family Comprehensive Cancer Center
Orange, California, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Louisville Oncology Clinical Research Program
Louisville, Kentucky, United States
- New Mexico Cancer Care Alliance
Albuquerque, New Mexico, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Gynecologic Oncology Research & Development, Llc
Greenville, South Carolina, United States
- Harrington Cancer Center
Amarillo, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2007
- Primary completion
- 30 Apr 2008
- Completion
- 30 Apr 2008
- Last update posted
- 10 Mar 2015
- Registered enrollment
- 17
- Registry id
- NCT00442598
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.